21645018Kamm MA, Hanauer SB, Panaccione R, Colombel JF, Sandborn WJ, Pollack PF, Zhou Q, Robinson AMAlimentary pharmacology & therapeuticsAnti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Crohn DiseaseAdalimumab; Adult; Double-Blind Method; Female; Glucocorticoids; Humans; Male; Middle Aged; Remission Induction; Time Factors; Treatment OutcomeAdalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease. Aliment Pharmacol Ther. 2011 Aug; 34(3):306-17.Aliment Pharmacol Ther2011-06-05T00:00:002011Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000328Living Beings1578255770.254432AdultD000893Chemicals & Drugs1513390.803694Anti-Inflammatory AgentsD003424Disorders1197290.61584Crohn DiseaseD005938Chemicals & DrugsPhysiology1793470.819927GlucocorticoidsD004311Procedures33818220.708936Double-Blind MethodD008875Concepts & IdeasLiving Beings1473249570.258811Middle AgedD005260Physiology1992444050.191167FemaleAuthorship 451632D006801Living Beings2262862810.130052HumansD013997Concepts & Ideas118351980.519628Time FactorsD008297Physiology1931408600.201617Male0.1028550.1028551authors10.2514has subject areaD016896Concepts & Ideas101179490.402389Treatment OutcomeD061067Chemicals & Drugs2139290.656166Antibodies, Monoclonal, HumanizedD00006887913800.940334AdalimumabD012074Procedures1657220.853019Remission InductionMedicineUniversity of ChicagoStephenHanauerStephen B. Hanauer41.78927490000000-87.60125000000000660Hanauer, StephenEmeritus/Emeritatrue1Emeritus/EmeritaEmeritus/Emerita